Stent with therapeutically active dosage of rapamycin coated thereon

US6585764B2 · kind B2 · utility

Assignee

• CORDIS CORPORATION · US

Inventors

• Carol Wright · Pittsburgh, US
• Gerard Llanos · Stewartsville, US
• Ronald Rakos · Neshanic Station, US
• Kristen King · Hoboken, US

Key dates

• Filing date: Jun 4, 2001
• Grant date: Jul 1, 2003
• Expiry date: Jun 4, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61L2300/606
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

Delivery of rapamycin locally, particularly from intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.